Gastric Organoids: Progress and Remaining Challenges

Min Jiao Pang, Joseph R. Burclaff, Ramon Jin, Mahliyah Adkins-Threats, Luciana H. Osaki, Yunan Han, Jason C. Mills, Zhi Feng Miao, Zhen Ning Wang

Research output: Contribution to journalReview articlepeer-review

13 Scopus citations

Abstract

The stomach is a complex and physiologically necessary organ, yet large differences in physiology between mouse and human stomachs have impeded translation of physiological discoveries and drug screens performed using murine gastric tissues. Gastric cancer (GC) is a global health threat, with a high mortality rate and limited treatment options. The heterogeneous nature of GC makes it poorly suited for current “one size fits all” standard treatments. In this review, we discuss the rapidly evolving field of gastric organoids, with a focus on studies expanding cultures from primary human tissues and describing the benefits of mouse organoid models. We introduce the differing methods for culturing healthy gastric tissue from adult tissues or pluripotent stem cells, discuss the promise these systems have for preclinical drug screens, and highlight applications of organoids for precision medicine. Finally, we discuss the limitations of these models and look to the future to present potential ways gastric organoids will advance treatment options for patients with GC.

Original languageEnglish
Pages (from-to)19-33
Number of pages15
JournalCMGH
Volume13
Issue number1
DOIs
StatePublished - Jan 2022

Keywords

  • Gastric Cancer
  • Organoids
  • Preclinical Trial
  • Stomach
  • Tumor Microenvironment

Fingerprint

Dive into the research topics of 'Gastric Organoids: Progress and Remaining Challenges'. Together they form a unique fingerprint.

Cite this